Top 3 Health Care Stocks That Could Blast Off In June

Group 1: Repligen Corp (RGEN) - Repligen appointed Olivier Loeillot as Chief Executive Officer, effective September 1 [3] - The company's stock has fallen approximately 28% over the past month, reaching a 52-week low of $110.45 [3] - The Relative Strength Index (RSI) for Repligen is at 22.62, indicating it is oversold [3] Group 2: Enovis Corp (ENOV) - Enovis reported better-than-expected quarterly results on May 2, with revenues and operating margins exceeding expectations [10] - Despite the positive results, the stock has decreased around 12% over the past month, with a 52-week low of $43.04 [10] - The RSI for Enovis is at 25.21, suggesting it is also in an oversold condition [10] Group 3: Penumbra Inc (PEN) - Penumbra announced upbeat quarterly earnings on May 7, yet its stock fell about 8% over the past five days [11] - The stock has a 52-week low of $170.59 [11] - The RSI for Penumbra is at 28.39, indicating it is nearing oversold territory [11]